Pramipexole dihydrochloride 1.5 MG Oral Tablet — RxCUI 859048
RxNorm drug concept · Semantic clinical drug
RxCUI 859048
Semantic clinical drug · SCD
● Current RxNorm concept 77 FDA products
170 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI859048
Official namePramipexole dihydrochloride 1.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspramipexole dihydrochloride 1.5 MG (equivalent to pramipexole 1 MG) Oral Tablet
FDA products mapped77
Package NDCs mapped170
Reported Medicaid activity (SDUD)188,121 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pramipexole: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats Parkinson’s disease. The immediate-release tablet is also approved for moderate-to-severe primary Restless Legs Syndrome. The extended-release tablet is for Parkinson’s d...
- Take it by mouth, with or without food, exactly as prescribed. Extended-release tablets are once daily and must be swallowed whole. Your dose is raised slowly, so don’t change it o...
- Be careful. Some people fell asleep suddenly during daily activities, including driving, sometimes with no warning. If you feel sleepy, don’t drive, and tell your doctor right away...
- Common ones are nausea, dizziness, sleepiness, trouble sleeping, constipation and weakness. Call your doctor if you have hallucinations, fainting, or new strong urges to gamble, sp...
🕸️ Concept Web — How Pramipexole dihydrochloride 1.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pramipexole dihydrochloride 1.5 MG Oral Tablet
RxCUI 859048 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Pramipexole
746741IN -
Pramipexole dihydrochloride
236747PIN
-
Pramipexole
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pramipexole Oral Tablet
745021SCDF -
Pramipexole dihydrochloride Oral Tablet
2645884SCDFP -
Pramipexole Oral Product
1161097SCDG -
Pramipexole Pill
1161689SCDG -
Pramipexole dihydrochloride Oral Product
2661805SCDGP -
Pramipexole dihydrochloride Pill
2660634SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Pramipexole Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pramipexole dihydrochloride 1.5 MG
859047SCDC
-
Pramipexole dihydrochloride 1.5 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pramipexole dihydrochloride 1.5 MG
SCDC · 859047 -
Pramipexole Oral Tablet
SCDF · 745021 -
Pramipexole dihydrochloride Oral Tablet
SCDFP · 2645884 -
Pramipexole Oral Product
SCDG · 1161097 -
Pramipexole Pill
SCDG · 1161689 -
Pramipexole dihydrochloride Oral Product
SCDGP · 2661805 -
Pramipexole dihydrochloride Pill
SCDGP · 2660634
📦 FDA Products & Package NDCs
77 products · 170 package NDCs
170 package NDCs map to RxCUI 859048 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13668-0091-05 | 500 TABLET in 1 BOTTLE (13668-091-05) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0091-30 | 30 TABLET in 1 BOTTLE (13668-091-30) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0091-42 | 6000 TABLET in 1 BOTTLE (13668-091-42) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0091-90 | 90 TABLET in 1 BOTTLE (13668-091-90) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0092-05 | 500 TABLET in 1 BOTTLE (13668-092-05) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0092-30 | 30 TABLET in 1 BOTTLE (13668-092-30) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0092-41 | 5500 TABLET in 1 BOTTLE (13668-092-41) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0092-90 | 90 TABLET in 1 BOTTLE (13668-092-90) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0093-05 | 500 TABLET in 1 BOTTLE (13668-093-05) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0093-30 | 30 TABLET in 1 BOTTLE (13668-093-30) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0093-40 | 4000 TABLET in 1 BOTTLE (13668-093-40) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0093-90 | 90 TABLET in 1 BOTTLE (13668-093-90) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0094-05 | 500 TABLET in 1 BOTTLE (13668-094-05) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0094-30 | 30 TABLET in 1 BOTTLE (13668-094-30) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0094-31 | 2500 TABLET in 1 BOTTLE (13668-094-31) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0094-90 | 90 TABLET in 1 BOTTLE (13668-094-90) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0095-05 | 500 TABLET in 1 BOTTLE (13668-095-05) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0095-15 | 1500 TABLET in 1 BOTTLE (13668-095-15) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0095-30 | 30 TABLET in 1 BOTTLE (13668-095-30) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0095-90 | 90 TABLET in 1 BOTTLE (13668-095-90) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0184-05 | 500 TABLET in 1 BOTTLE (13668-184-05) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0184-30 | 30 TABLET in 1 BOTTLE (13668-184-30) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0184-31 | 2500 TABLET in 1 BOTTLE (13668-184-31) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 13668-0184-90 | 90 TABLET in 1 BOTTLE (13668-184-90) | Pramipexole Dihydrochloride | Torrent Pharmaceuticals Limited | 2010-10-08 |
| 29300-0207-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-207-10) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0207-16 | 60 TABLET in 1 BOTTLE, PLASTIC (29300-207-16) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0207-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-207-19) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0208-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-208-10) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0208-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-208-19) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0209-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-209-10) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0209-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-209-19) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0210-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-210-10) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0210-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-210-19) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0211-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-211-10) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0211-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-211-19) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0270-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-270-10) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 29300-0270-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-270-19) | pramipexole dihydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2019-03-01 |
| 31722-0906-05 | 500 TABLET in 1 BOTTLE (31722-906-05) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0906-10 | 1000 TABLET in 1 BOTTLE (31722-906-10) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0906-90 | 90 TABLET in 1 BOTTLE (31722-906-90) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0907-05 | 500 TABLET in 1 BOTTLE (31722-907-05) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0907-10 | 1000 TABLET in 1 BOTTLE (31722-907-10) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0907-90 | 90 TABLET in 1 BOTTLE (31722-907-90) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0908-05 | 500 TABLET in 1 BOTTLE (31722-908-05) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0908-10 | 1000 TABLET in 1 BOTTLE (31722-908-10) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0908-90 | 90 TABLET in 1 BOTTLE (31722-908-90) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0909-05 | 500 TABLET in 1 BOTTLE (31722-909-05) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0909-10 | 1000 TABLET in 1 BOTTLE (31722-909-10) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0909-90 | 90 TABLET in 1 BOTTLE (31722-909-90) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
| 31722-0910-05 | 500 TABLET in 1 BOTTLE (31722-910-05) | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | 2015-08-01 |
Observed labelers:
Torrent Pharmaceuticals Limited (24) ·
Macleods Pharmaceuticals Limited (20) ·
Aurobindo Pharma Limited (18) ·
Camber Pharmaceuticals, Inc. (18) ·
Glenmark Pharmaceuticals Inc., USA (18) ·
Unichem Pharmaceuticals (USA), Inc. (13)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.